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Abstract
Introduction: Aortic valve replacement (AVR) is the gold stan-
dard in treating symptomatic aortic valve defects. To improve 
the healing process and limit the trauma, the minimally inva-
sive approach was introduced.
Aim: To compare the peri- and post-operative results of aortic 
valve replacement performed via conventional full sternotomy 
(con-AVR) and of AVR performed via partial upper sternotomy 
(mini-AVR).
Material and methods: The total study population was di-
vided into 2 demographically homogeneous groups: mini-AVR 
(n = 74) and con-AVR (n = 76). There were no statistically sig-
nificant differences in preoperative echocardiography.
Results: Aortic cross-clamp time and cardiopulmonary bypass 
time were significantly longer in the mini-AVR group. Shorter 
mechanical ventilation time, hospital stay and lower postoper-
ative drainage were observed in the mini-AVR group (p < 0.05). 
Biological prostheses were more frequently implanted in the 
mini-AVR group (p < 0.05). Patients from the mini-AVR group 
reported less postoperative pain. No significant differences 
were found in the diameter of the implanted aortic prosthesis, 
the amount of inotropic agents and painkillers, postoperative 
left ventricular ejection fraction (LVEF), medium and maximum 
transvalvular gradient or the number of transfused blood 
units. There were no differences in the frequency of postopera-
tive complications such as mortality, stroke, atrial fibrillation, 
renal failure, wound infection, sternal instability, or the need 
for rethoracotomy.
Conclusions: Ministernotomy for AVR is a safe method and 
does not increase morbidity and mortality. It significantly re-
duces post-operative blood loss and shortens hospital stay. 
Ministernotomy can be successfully used as an alternative 
method to sternotomy.
Key words: ministernotomy, aortic valve replacement, mini-
aortic valve replacement, sternotomy.
Streszczenie
Wprowadzenie: Chirurgiczna wymiana zastawki aortalnej 
(AVR) jest złotym standardem leczenia objawowych wad za-
stawki aortalnej. Małoinwazyjny dostęp chirurgiczny pomaga 
zminimalizować uszkodzenie tkanek oraz usprawnia procesy 
gojenia rany pooperacyjnej. 
Cel: Porównanie okołooperacyjnych oraz pooperacyjnych wyni-
ków leczenia AVR wykonywanej przez sternotomię pośrodkową 
(con-AVR) oraz poprzez częściową sternotomię górną (mini-AVR). 
Materiał i metody: Pacjentów włączonych do badania podzie-
lono na dwie demograficznie homogenne grupy: mini-AVR 
(n = 74) i con-AVR (n = 76). Nie było różnic między grupami 
w wynikach przedoperacyjnego badania echokardiograficznego. 
Wyniki: Czas zakleszczenia aorty i czas krążenia pozaustrojo-
wego były dłuższe w grupie mini-AVR, w której obserwowa-
no również krótszy czas wentylacji mechanicznej i hospitali-
zacji oraz mniejszy drenaż pooperacyjny (p < 0,05). W grupie 
mini -AVR częściej wszczepiano zastawki biologiczne. Pacjenci 
z grupy mini-AVR zgłaszali niższe natężenie bólu po operacji 
(p < 0,05). Nie obserwowano istotnych statystycznie różnic pod 
względem średnicy implantowanych zastawek, stosowanych 
leków inotropowych, leków przeciwbólowych, pooperacyjnej 
frakcji wyrzutowej, średnich i maksymalnych gradientów za-
stawkowych oraz ilości przetaczanej krwi pomiędzy grupami. 
Nie stwierdzono również różnic w występowaniu komplikacji 
pooperacyjnych, takich jak zgon, udar, migotanie przedsion-
ków, niewydolność nerek, infekcje rany, niestabilność mostka 
i powtórne otwarcie klatki piersiowej. 
Wnioski: Ministernotomia jest bezpiecznym dostępem chirur-
gicznym podczas AVR, który nie zwiększa ryzyka wystąpienia 
powikłań, w tym zgonu. Mini-AVR znacząco zmniejsza poope-
racyjną utratę krwi i skraca czas pobytu w szpitalu. Może być 
z sukcesem stosowana jako alternatywa dla pełnej sternotomii. 
Słowa kluczowe: ministernotomia, wymiana zastawki aortal-
nej, małoinwazyjna wymiana zastawki aortalnej, sternotomia.
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Introduction
Aortic valve malformation is the fourth most common 
cardiovascular problem in the modern world, affecting 
2–7% of patients aged 65 or older [1]. The most common 
type of defect is aortic stenosis mainly caused by valve de-
generation. If left untreated, it leads to myocardial hyper-
trophy and prolongation of left ventricular ejection time, 
which causes deterioration of contractility, left ventricular 
size enlargement and increase of end-diastolic pressure. 
Pharmacological treatment helps to relieve symptoms, but 
still aortic valve replacement (AVR) is the standard treat-
ment for hemodynamically significant aortic valve disease.
In recent years, two approaches have emerged in surgi-
cal aortic valve replacement: full conventional sternotomy 
(con-AVR) and minimally invasive aortic valve replacement 
(mini-AVR). Compared to con-AVR, the mini-AVR approach 
is technically challenging and more demanding with 
a reduced surgical field. Limited access to the heart and 
a smaller operative field may increase the surgical risk. On 
the other hand, mini-AVR shows better cosmetic effects, 
a lower level of postoperative pain, shorter intensive care 
unit (ICU) stay, and generally shorter hospitalization. How-
ever, there is no clear superiority of either approach [2–5].
Aim
The aim of the study was to compare the early out-
comes of aortic valve replacement performed through con-
ventional full sternotomy (con-AVR) and of AVR through 
less invasive J-shaped hemisternotomy (mini-AVR).
Material and methods
A retrospective, single-center study was performed in 
patients undergoing isolate surgical aortic valve replace-
ment. Inclusion and exclusion criteria are shown in Table I. 
Patients were divided into two groups depending on the 
procedure approach: mini-AVR and con-AVR.
Surgical technique
In each group, con-AVR and mini-AVR, all procedures 
were performed by a group of four experienced surgeons. 
In each case, the decision on the method used and on the 
prosthesis type and size was made by the implanting sur-
geon. No aortic annulus enlargement techniques were used.
Minimally invasive aortic valve replacement was per-
formed via a 7–8 cm skin incision from the level of the head 
of the second rib in the midline over the sternum and down 
to the level of the head of the fourth intercostal space. The 
reserved J-shaped approach was obtained by making an in-
cision along the mid-line of the sternum from the jugular 
notch to the fourth intercostal space.
Conventional sternotomy was approached by tradition-
al median sternotomy, which was followed by aortic and 
right atrium cannulation with vacuum suction.
Cold-crystalloid or cold-blood cardioplegic solution was 
administered anterogradely, and then retrogradely every 
20 min after opening the aorta.
Statistical analysis
Values are given as mean ± standard deviation. The 
Shapiro-Wilk test was performed to determine the normal 
distribution. To compare continuous variables between 
groups that had a normal distribution, an independent 
t-test was used. Continuous variables that did not exhibit 
a normal distribution were compared with the Mann-Whit-
ney U-test. All dichotomous variables were compared using 
χ2 analysis or the Kolmogorov-Smirnov test. A p-value of 
less than 0.05 was considered statistically significant. Sta-
tistical analysis was performed using Statistica 10 software 
(StatSoft Inc., Tulsa, OK, USA).
Results
A total of 150 patients were enrolled in the study: 74 pa- 
tients who underwent mini-AVR and 76 patients who un-
Table I. Inclusion and exclusion criteria
Inclusion criteria Exclusion criteria
• Age ≥ 18
• Caucasian race
• Symptomatic aortic valve defect requiring cardiac surgery
• Echocardiographic diagnosis of isolated aortic valve 
malformation: aortic stenosis, aortic insufficiency, combined 
defect of aortic valve
• Current New York Heart Association (NYHA) stage ≥ 1
• Life expectancy ≥ 1 year
• Previous cardiac surgery
• Defects of other heart valves requiring surgical correction
• Myocardial infarction or unstable angina in previous 3 months
• Coexisting ischemic heart disease requiring coronary artery bypass 
grafting (CABG)
• Current right ventricular heart insufficiency
• Current cardiogenic shock on hemodynamic instability
• Need for intra-aortic counterpulsation or inotropic agents intravenously
• Need for urgent operation
• Current or previous endocarditis
• Left ventricular ejection fraction (LVEF) < 30%
• Previous thoracic injury
• Deformation of the thorax
• Severe scoliosis
• Current systemic infection
• Diagnosed autoimmune disease with known association with 
pericarditis (e.g. collagenosis)
• Mental retardation or another disease which may preclude 
understanding risks and benefits connected with the operation
• Severe stage of chronic obstructive pulmonary disease (COPD)
• Diagnosed cancer limiting survival below 12 months
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derwent con-AVR. Baseline characteristics are summarized 
in Table II. Patients were matched for age, body mass in-
dex (BMI), gender and comorbidities. Preoperative trans-
thoracic echocardiography results are summarized in Ta- 
ble III. Groups were similar for type of valve pathology, valve 
type, left ventricular ejection fraction (LVEF), maximal and 
mean aortic gradient, indexed aortic valve area (iAVA), left 
ventricular posterior wall (LVPW) and intraventricular sep-
tum (IVS). In the mini-AVR group mean aortic gradient was 
71.6 ±22.8 mm Hg and was higher as compared to con-AVR, 
53.0 ±20.5 mm Hg.
Procedure parameters
In the mini-AVR group aortic cross-clamp time (ACC), 
cardiopulmonary bypass time (CBP) and total operation 
time were longer than in the con-AVR group. All differences 
between groups were statistically significant (Table IV).
Type of prosthesis and diameters
In the mini-AVR group, 3 (4%) patients had an ATS me-
chanical aortic valve implanted, while 71 (96%) patients re-
ceived a biological aortic prosthesis. As many as 51 patients 
had a Carpentier-Edwards Perimount valve implanted and 
another 20 had a Medtronic Hancook II. In the AVR group, 
a mechanical prosthesis was implanted in 17 (22%) pa-
tients, an ATS in 9 patients and a St. Jude Medical Master 
in 8 patients. In the con-AVR group a biological prosthesis 
was implanted in 59 (78%) patients, a Carpentier-Edwards 
Perimount valve in 44 patients, and a Medtronic Hancook II 
in 15 patients. The differences were statistically significant 
(p = 0.006) (Fig. 1).
In the mini-AVR group, the median prosthesis diameter 
was 23 mm (21–25 mm) and in the con-AVR group it was 
23 mm (23–25 mm) (Fig. 2). No statistically significant dif-
ference was observed in aortic prosthesis diameter or ap-
proach used during the operation (p > 0.05).
Postoperative transthoracic echocardiography exami-
nation in the mini-AVR group showed LVEF of 50% (38–
50%), maximal aortic gradient of 24 mm Hg (19–29 mm Hg) 
and mean aortic gradient of 14 mm Hg (11–18 mm Hg). In 
the con-AVR group LVEF was 45% (30–49%), maximal aortic 
gradient was 24 mm Hg (16–28 mm Hg) and mean aortic 
gradient was 12 mm Hg (9–17 mm Hg). Differences were 
statistically insignificant (p > 0.05).
Clinical outcomes
In the mini-AVR group 41 (57%) patients received ino-
tropic drugs and in the con-AVR group 51 (63%) patients 
did. The difference was statistically insignificant (p > 0.05). 
In the mini-AVR group median time of mechanical ventila-
tion was 8 (6–14) h and for the con-AVR group the median 
time was 10 (6–18) h. The difference was statistically sig-
nificant (p = 0.045). To assess postoperative pain, the Nu-
merical Rating Scale (NRS) 0–10 was used. In the mini-AVR 
group, the intensity of pain was lower in comparison to the 
con-AVR group and the result was statistically significant 
Table II. Demographic and comorbidity data
Parameter Mini-AVR Con-AVR P-value
Gender:
Female 47.3% (35) 38.2% (29) > 0.05
Male 52.7% (39) 61.8% (47)
Age [years] 68 (57–77) 66 (52–73) > 0.05
BMI [kg/m2] 28.21 ±4.36 28.28 ±5.46 > 0.05
EuroSCORE 7 (3–10) 7 (3–11) > 0.05
NYHA: 2 (2–3) 2 (2–3) > 0.05
NYHA I 7.6% 24.5%
NYHA II 51.5% 40.8%
NYHA III 39.4% 34.7%
NYHA IV 1.5% 0%
CCS: 2 (1–2) 1 (1–2) 0.007
CCS 0 1.5% 19.1%
CCS I 40.0% 44.7%
CCS II 46.2% 29.8%
CCS III 12.3% 6.4%
History of MI 23.3% 38.6% > 0.05
Previous PCI 9.6% 19% > 0.05
Diabetes mellitus type II 23% 17% > 0.05
Obesity 38% 25% > 0.05
Hypertension 67.5% 67% > 0.05
Atrial fibrillation 24.3% 17.2% > 0.05
Peripheral vessel disease 16% 12% > 0.05
COPD 8% 7% > 0.05
History of stroke 3% 8% > 0.05
Table III. Preoperative transthoracic echocardiography results
Parameter Mini-AVR Con-AVR P-value
Type of aortic defect:
Stenosis 77% 75.9% > 0.05
Aortic insufficiency 8.1% 19.0%
Combined defect (SA + IA) 14.9% 5.2%
Bicuspid valve 76.4% 71.7% > 0.05
LVEF (%) 60 (52–63) 60 (55–65) > 0.05
Max. gradient [mm Hg] 98 (78–110) 95 (75–100) > 0.05
Mean gradient [mm Hg] 71.6 ±22.8 53 ±20.5 0.002
iAVA [cm2/m2] 0.8 (0.6–1.2) 0.5 (0.5–0.8) > 0.05
LVPW [cm] 1.4 (1.2–1.6) 1.3 (1.2–1.6) > 0.05
IVS [cm] 1.5 (1.4–1.7) 1.5 (1.3–1.6) > 0.05
Table IV. Comparison of ACC, CBP and total operation time de-
pending on used approach
Parameter Mini-AVR Con-AVR P-value
ACC [min] 75 (64–87) 55 (50–63) < 0.001
CBP [min] 127 (116–140) 97 (90–123) < 0.001
Total operation  
time [min]
240 (210–240) 200 (180–230) < 0.001
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(p < 0.05). No statistically significant differences were ob-
served between groups for time of use of any analgesics: 
opioids, paracetamol, or NSAIDs. No statistically significant 
differences were observed in the level of postoperative he-
moglobin between groups; the median for mini-AVR was 
10.5 (10.1–1.4) g/dl and for con-AVR 10.3 (9.6–11.2) g/dl. Me-
dian postoperative drainage in the mini-AVR group was 360 
(130–1300) ml and was lower than in the con-AVR group, 
with the median of 590 (180–2300) ml (p < 0.001). No statis-
tically significant difference was observed in the amount of 
patients requiring transfusion of red cell concentrate (27% 
of patients in the mini-AVR group vs. 34% in the con-AVR 
group). In the mini-AVR group, the frequency of transfusion 
of fresh frozen plasma (FFP) was 15% and was statistically 
significantly lower than in the group of con-AVR patients, 
where it was 32% (p = 0.01). In the mini-AVR group, 9% 
of patients needed platelet concentrate transfusion and in 
the con-AVR group 18%. No statistically significant differ-
ences in the number of deaths or the length of ICU stay 
were observed. The in-hospital stay was statistically signifi-
cantly (p = 0.02) longer in the group of con-AVR patients 
and averaged 8 days in comparison to 7 days in the case of 
mini-AVR patients. In the mini-AVR group one person was 
diagnosed with acute kidney injury requiring hemodialysis. 
No strokes were observed in the whole study. No significant 
differences were observed in the frequency of postopera-
tive AF (9.4% in mini-AVR vs. 19.7% in con-AVR), the need 
for repeated suturing of the sternum (1.3% in mini-AVR vs. 
5.2% in con-AVR group), or the amount of surgical reinter-
ventions due to bleeding procedures (1.3% in mini-AVR vs. 
5.2% in con-AVR).
Discussion
Over the past years, less invasive approaches have be-
come more popular in cardiac surgery of adults.
As compared to sternotomy, ministernotomy is less 
traumatic, provides better stability of the sternum and tho-
rax, accelerates the healing process and ensures a better 
cosmetic effect with fewer deep sternal wound complica-
tions [6]. Additionally, ministernotomy appears to be the 
safest of all minimally invasive methods, because it can be 
easily converted to full sternotomy. Also, patients tend to 
choose a less invasive method, if possible. However, there 
are some limitations of ministernotomy: it restricts access 
to the ascending aorta, limits the operation field and im-
pedes visualization for the operator and assistant surgeon 
during the whole operation. It may also prolong the time 
of the operation. Because of that, mini-AVR is technically 
more demanding for a cardiac surgeon and requires more 
experience and abilities. There are many controversies con-
cerning the advantages and disadvantages of mini-AVR in 
the current literature.
Prolonged ACC, CPB and total operation time are con-
sidered to be among the biggest disadvantages of the 
mini-AVR technique. Some authors believe that prolonga-
tion of CPB and ACC puts patients at risk of complications, 
which could have been avoided with classic sternotomy. In 
addition, partial cutting of the sternum results in difficul-
ties in the assessment of contractility of myocardium, ven-
tricular refill and problems with venting the heart [7]. It was 
proven that prolonged ACC and CPB are independent risk 
factors of cardiovascular complications such as low cardiac 
output, stroke, acute kidney injury and increased risk of 
perioperative death. Ranucii et al. reported that 1 min of 
ACC in patients undergoing AVR is an independent risk fac-
tor increasing the risk of cardiovascular complications [8]. 
A study conducted by Salis et al. showed that prolonging 
CPB for over 30 min also increases the risk of that compli-
cation [9]. In addition, some authors believe that prolonged 
CPB causes a systemic inflammatory reaction, which may 
lead to multiorgan failure [10]. Brown et al. demonstrated 
in their meta-analysis that the parameters CPB, ACC and 
total operation time are significantly longer for minister-
notomy than for sternotomy. For ACC, the weighted mean 
difference was 7.9 min (3.5–12.3 min), for CPB 11.46 min 
(5.26–17.65 min), and for total operation time 1.58 min 
(2.7–28.46 min) [2]. In our study, ACC, CPB and operation 
time were similar to the results found in the literature.
Fig. 1. Type of prosthesis depending on surgical approach groups 
(ministernotomy vs. sternotomy) (p = 0.006)
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Fig. 2. Diameter of implanted prosthesis depending on used ap-
proach (p > 0.05)
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A compensatory mechanism in aortic valve defects 
causes left ventricular hypertrophy (LVH), which is an in-
dependent risk factor of cardiovascular complications and 
sudden cardiac death. The LVH increases the risk of stroke, 
ischemic heart disease occurrence and peripheral vascular 
disease and may cause ventricular arrhythmias. The risk in-
creases even more if LVH coexists with aortic stenosis. Re-
search by Lund et al. showed that the lack of left ventricular 
hypertrophy reduction after AVR significantly reduces the 
10-year survival [11]. In the case of improper fit of the pros-
thesis to the patient’s body surface area there is a risk of 
incomplete paravalvular gradient reduction after the oper-
ation and patient-prosthesis mismatch (PPM) occurrence. 
A previous study showed that PPM is more common after 
ministernotomy than sternotomy [12]. Increased transval-
vular gradient leads to faster degeneration of an implanted 
biological prosthesis, which causes sooner reoperation and 
worsens the survival rate [13].
In contrast to the CABG procedure, in patients undergo-
ing AVR, left ventricular contractility disorders do not resolve 
after the operation. In patients with normal preoperative left 
ventricular systolic function contractility disorders may oc-
cur in 4–6 h after the operation and usually subside in 24 h. 
Therefore, in the postoperative period, inotropic drugs are 
indicated. Factors that may increase the need for inotro-
pic drugs are the following: elderly age, cardiomegaly, sex, 
reduced ejection fraction, urgency of the operation, previ-
ous MI, prolonged ACC or CPB [14–16]. As it was shown in 
our study, ACC and CPB are longer in ministernotomy AVR 
procedures. So far, only Szwerc et al. have investigated the 
influence of ACC and CBP and found that in patients after 
ministernotomy the need for inotropic drugs was higher than 
in patients after sternotomy, but their study showed no dif-
ference in the length of CPB and ACC [17]. In our study there 
was no statistically significant difference in inotropic drug 
supply. Inotropic drugs were used when clinical signs of heart 
failure occurred. There are no guidelines on the treatment of 
contractility disorders in our center; thus the decision on ino-
tropic drug therapy is a subjective decision of the surgeon or 
ICU physician and it is not dependent on the approach used.
Respiratory failure and prolonged mechanical ventila-
tion in patients after cardiac surgery operations consti-
tute a very important factor increasing the risk of periop-
erative death and in-hospital readmission to the ICU [18]. 
The frequency of respiratory failure after cardiac surgery is 
estimated at 5–20% [19]. In the literature the mechanical 
ventilation time was significantly shorter in the mini-AVR 
group than in the AVR group and the frequency of respira-
tory failure was statistically lower in the mini-AVR group 
[3, 5, 20]. In our study, the median time of mechanical ven-
tilation was statistically significantly shorter for the mini-
AVR group than for the AVR group. Moreover, between the 
analyzed groups there was no difference in the frequency 
of respiratory diseases, which might have influenced the 
results. The ministernotomy approach decreases postop-
erative mechanical ventilation time and diminishes the risk 
of respiratory failure in the mini-AVR group.
The influence of ministernotomy on the reduction of 
postoperative bleeding remains unclear. The majority of 
publications conclude that postoperative drainage is sig-
nificantly lower in mini-AVR patients than in AVR patients. 
However, postoperative blood loss depends not only on 
surgical approaches or surgeon experience but also on 
various other factors such as preoperative medications or 
coagulopathy [5, 20–22].
In our study, the median drainage was 230 ml lower in 
ministernotomy than in sternotomy procedures. Minister-
notomy reduces postoperative bleeding because it causes 
less trauma to the tissue and a smaller inflammatory re-
sponse [10]. When assessing postoperative blood loss with 
the amount of transfusions, investigators can avoid error 
resulting from use of anticoagulation drugs, extracorporeal 
circulation (ECC) and operation time length. Only one study 
showed lower incidence of blood transfusions in the mini-
AVR group, but the amount of units transfused was practi-
cally equal in both groups. In our study and many other 
papers, there were no differences in the number of blood 
units, transfused blood volume, or number of patients re-
quiring transfusion [3, 17, 20, 23]. However, because there 
is no uniform blood transfusion scheme after cardiac pro-
cedures at our center, the time from operation to trans-
fusion, and the number of transfused blood units, can be 
different and does not constitute a perfect method of post-
operative blood loss estimation. Additionally, postoperative 
blood loss does not depend only on surgical approaches 
or surgeon experience, but is also a result of other factors 
such as preoperative treatment or coagulopathy [5, 20–22]. 
Therefore, interpretation and comparison of the results is 
difficult. We conclude that ministernotomy does not reduce 
the need for blood transfusion, but reduces postoperative 
drainage because of reduced tissue damage and produc-
tion of inflammatory factors.
Several studies have confirmed that patients after mini-
AVR experienced less pain than patients after con-AVR. 
Bonacchi et al. observed lower intake of morphine dur-
ing the first 12 h after the operation and lower intake of 
NSAIDs in the first 72 h [3]. In our study we observed sta-
tistically significantly lower pain intensity on the NRS scale 
in the group of mini-AVR, but no differences in the length 
of painkiller intake.
The length of ICU stay and hospital stay were shorter 
in the mini-AVR group according to many authors [3, 20]. 
In our study, data were similar but we achieved a statisti-
cally significant result only for the length of hospital stay. 
We did not observe a statistically significant difference in 
in-hospital mortality between groups, similarly to previous 
studies [3–5].
In this paper, the major complications were analyzed 
and the results were compared to the literature. Results 
concerning postoperative AF are unclear; some authors 
stated that mini- AVR may have a higher risk of that ar-
rhythmia, but others reported a lower risk [3, 24]. In our 
study we observed a statistically insignificantly lower fre-
quency of AF in the mini-AVR group. We did not observe 
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stroke in the whole study. However, it should be noted that 
during the AVR procedure, left atrial appendage closure 
may be performed to prevent thromboembolic complica-
tions with surgical techniques or dedicated devices [25].
Only 1 case of acute kidney injury and hemodialysis 
therapy was observed, and the patient underwent mini-
AVR. In the literature, no significant association was ob-
served [24]. The frequency of resternotomy procedure, ster-
nal dehiscence, and the need for repeated suturing of the 
sternum was lower in the mini-AVR group, but the differ-
ence was not statistically significant. Observations of other 
authors are similar [3, 24].
Conclusions
Basing on our observations and literature review we 
conclude that ministernotomy is a safe approach to perform 
aortic valve replacement. It may be used as an alternative 
to full sternotomy, but requires more experience than the 
classic approach. Observations show that postoperative 
outcomes are comparable or even better for the mini-AVR 
group in comparison to the AVR group. Ministernotomy 
may reduce the costs of the hospitalization by shortening 
the in-hospital stay. Also patients’ choice is a very impor-
tant aspect, as patients would prefer less pain and a bet-
ter cosmetic effect. Therefore, ministernotomy seems to be 
a valuable option for our patients.
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